Tuesday, August 6, 2024, from 2:00 PM ET to 3:00 PM ET • Sponsored by AST's Inclusion, Diversity, Equity, and Access to Life (IDEAL) Committee
Organ Transplantation and "The role of race and ethnicity in health care crowdfunding: an exploratory analysis"
(Health Aff Sch. 2024 Feb 28;2(3):qxae027. doi: 10.1093/haschl/qxae027. eCollection 2024 Mar.)
After participating in this webinar, the attendee will be able to:
Tuesday, October 31st, 2023, from 2:00 PM ET to 3:00 PM ET • Sponsored by AST's Women's Health Community of Practice (WHCOP) and Psychosocial and Ethics Community of Practice (PSECOP)
"Inequities in organ and tissue donation and transplantation for sexual orientation and gender identity diverse people: A scoping review"
(Am J Transplant. 2023 Jun;23(6):707-726. doi: 10.1016/j.ajt.2023.03.016. Epub 2023 Mar 29.)
The Immuno Bill is a Reality! Guidance for the New “Medicare Part B-ID"
- Wednesday, November 2, 2022 - 2:00 pm to 3:00 pm EDT
Speakers:
- Matthew Cooper, MD, FAST • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
- Nancy Edgington, LCSW III, CCTSW • Lead Kidney Transplant Social Worker, Yale New Haven Hospital, New Haven, CT
- Jennifer McDermott, PharmD, BCTXP, BCPS • Clinical Pharmacy Specialist, Solid Organ Transplant, Spectrum Health, Grand Rapids, MI
Moderator:
- Lisa Potter, PharmD, BCTXP, FCCP, FAST • Clinical Coordinator, Organ Transplant, University of Chicago Medicine, Chicago, IL
This topic was suggested by the AST Education Committee for inclusion in the 2022-2023 T3 webinar series. The Committee would like to thank the leadership of AST's Transplant Pharmacy Community of Practice (TxPharm COP) for their feedback on session speakers.
Recorded live on Thursday, February 24, 2022 from 2:00 PM ET to 3:00 PM ET • Hosted jointly by AST's Living Donor Community of Practice (LDCOP) and Psychosocial and Ethics Community of Practice (PSECOP)
"Transplant social worker and donor financial assistance to increase living donor kidney transplants among African Americans: The TALKS Study, a randomized comparative effectiveness trial" (Randomized Controlled Trial > Am J Transplant. 2021 Jun;21(6):2175-2187. doi: 10.1111/ajt.16403. Epub 2021 Jan 4.)
After participating in this webinar, the attendee will be able to:
Speakers:
Richard Formica, MD • Professor of Medicine, Yale University, New Haven, CT
William Applegate • AST Director of Government Relations; Senior Policy Advisor, Bryan Cave Leighton Paisner, St. Louis, MO & Washington D.C.
Moderator:
Beau Kelly, MD, MBA, FACS, FAST • Surgical Director, DCI Donor Services, Inc., Sacramento, CA
This topic was developed by the AST Education Committee in response to recent policy and legislation activity related to the "Executive Order on Advancing American Kidney Health," the "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (the "Immuno Bill"), and other topics that are important to the field of transplantation.
Speakers:
Richard Formica, MD • Professor of Medicine, Yale University, New Haven, CT
William Applegate • AST Director of Government Relations; Senior Policy Advisor, Bryan Cave Leighton Paisner, St. Louis, MO & Washington D.C.
Moderator:
Beau Kelly, MD, MBA, FACS, FAST • Surgical Director, DCI Donor Services, Inc., Sacramento, CA
Objectives for the "Breaking News in Federal Policy in Organ Transplantation" webinar include:
The goal of the Transplant Patient Summit is to invite two transplant recipients or donors from each state to help them become transplant ambassadors and empower them to advocate for the field of transplantation from both a legislative/regulatory and fundraising capacity. The AST will provide a stipend for travel costs and will cover each attendee or live donor's hotel stay. For more information, please visit our Power2Save page.
ASTS and AST are pleased to offer a free one-hour webinar to provide additional information and answer questions related to the call for commitments at the White House Organ Summit in June. The webinar will feature Jennifer Erickson from the White House Office of Science & Technology Policy.
